tiprankstipranks
Quantum Genomics Societe Anonyme (FR:ALQGC)
:ALQGC
France Market
ALQGC
Quantum Genomics Societe Anonyme
RESEARCH TOOLSreports

Quantum Genomics Societe Anonyme (ALQGC) Ratios

― Followers

Quantum Genomics Societe Anonyme Ratios

FR:ALQGC's free cash flow for Q4 2024 was €-83.65K. For the 2024 fiscal year, FR:ALQGC's free cash flow was decreased by € and operating cash flow was €-116.97K. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 2.05 2.05 2.73 1.33 2.57
Quick Ratio
 2.05 2.05 2.73 1.33 2.57
Cash Ratio
 1.75 1.75 2.63 0.59 1.72
Solvency Ratio
 -3.16 -3.16 -0.88 -1.23 -1.47
Operating Cash Flow Ratio
 0.00 0.00 0.00 -1.15 -2.16
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 -104.40
Net Current Asset Value
€ -2.46M€ -2.46M€ 377.14K€ 3.34M€ 8.66M
Leverage Ratios
Debt-to-Assets Ratio
 7.44 7.44 0.73 0.13 0.16
Debt-to-Equity Ratio
 -1.07 -1.07 6.22 0.84 0.36
Debt-to-Capital Ratio
 14.44 14.44 0.86 0.46 0.26
Long-Term Debt-to-Capital Ratio
 14.44 14.44 0.82 0.46 0.23
Financial Leverage Ratio
 -0.14 -0.14 8.58 6.56 2.20
Debt Service Coverage Ratio
 -1.82 -1.82 -3.65 -1.56K -80.97
Interest Coverage Ratio
 -53.51 -53.51 -146.59 -1.70K -437.24
Debt to Market Cap
 0.68 0.68 0.74 0.74 0.03
Interest Debt Per Share
 0.04 0.04 0.08 0.09 0.13
Net Debt to EBITDA
 -1.59 -1.59 0.29 0.24 0.52
Profitability Margins
Gross Profit Margin
-11453070.00%-11453070.00%-7169.57%-1073.02%-548.31%
EBIT Margin
-14728340.00%-14728340.00%-15847.91%-1211.23%-631.10%
EBITDA Margin
-14702370.00%-14702370.00%-14515.46%-1200.75%-618.67%
Operating Profit Margin
-14728350.00%-14728350.00%-15847.92%-1196.12%-640.95%
Pretax Profit Margin
-88926030.00%-88926030.00%-16192.05%-1092.80%-632.57%
Net Profit Margin
-88926030.00%-88926030.00%-16018.12%-991.45%-553.19%
Continuous Operations Profit Margin
-88926030.00%-88926030.00%-16018.12%-991.45%-553.19%
Net Income Per EBT
100.00%100.00%98.93%90.72%87.45%
EBT Per EBIT
603.77%603.77%102.17%91.36%98.69%
Return on Assets (ROA)
-2507.44%-2507.44%-84.63%-105.40%-81.72%
Return on Equity (ROE)
880.77%362.09%-726.18%-691.19%-179.57%
Return on Capital Employed (ROCE)
-806.14%-806.14%-130.88%-495.72%-150.38%
Return on Invested Capital (ROIC)
-153.05%-153.05%-98.42%-452.26%-128.73%
Return on Tangible Assets
-2507.44%-2507.44%-84.63%-105.40%-83.84%
Earnings Yield
-176.93%-176.93%-85.82%-612.03%-15.02%
Efficiency Ratios
Receivables Turnover
 <0.01 <0.01 0.00 0.19 4.51
Payables Turnover
 7.88 7.88 5.29 1.84 3.02
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 <0.01 <0.01 2.51 109.58 7.10
Asset Turnover
 <0.01 <0.01 <0.01 0.11 0.15
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 0.28 0.17
Cash Conversion Cycle
 1.00M 1.00M -69.04 1.67K -40.08
Days of Sales Outstanding
 1.00M 1.00M 0.00 1.87K 80.96
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 46.34 46.34 69.04 198.05 121.03
Operating Cycle
 1.00M 1.00M 0.00 1.87K 80.96
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 0.00 0.00 -0.59 -0.63
Free Cash Flow Per Share
 0.00 0.00 0.00 -0.59 -0.63
CapEx Per Share
 0.00 0.00 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 0.00 0.00 0.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 -378.16
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 -378.16
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 -6.66 -4.92
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 -8.04 -5.42
Free Cash Flow Yield
0.00%0.00%0.00%-496.12%-14.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.57 -0.57 -1.17 -0.16 -6.66
Price-to-Sales (P/S) Ratio
 499.95K 502.59K 186.65 1.62 36.83
Price-to-Book (P/B) Ratio
 -2.05 -2.05 8.46 1.13 11.95
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 0.00 0.00 -0.20 -6.77
Price-to-Operating Cash Flow Ratio
 0.00 0.00 0.00 -0.20 -6.79
Price-to-Earnings Growth (PEG) Ratio
 -0.08 -0.01 0.01 -0.01 0.35
Price-to-Fair Value
 -2.05 -2.05 8.46 1.13 11.95
Enterprise Value Multiple
 -4.99 -5.01 -1.00 0.11 -5.43
Enterprise Value
 7.34M 7.36M 2.86M -3.29M 105.47M
EV to EBITDA
 -4.99 -5.01 -1.00 0.11 -5.43
EV to Sales
 733.71K 736.35K 144.69 -1.31 33.61
EV to Free Cash Flow
 0.00 0.00 0.00 0.16 -6.18
EV to Operating Cash Flow
 0.00 0.00 0.00 0.16 -6.20
Tangible Book Value Per Share
 -0.04 -0.04 0.01 0.10 0.34
Shareholders’ Equity Per Share
 -0.04 -0.04 0.01 0.10 0.36
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.01 0.09 0.13
Revenue Per Share
 <0.01 <0.01 <0.01 0.07 0.12
Net Income Per Share
 -0.13 -0.13 -0.09 -0.72 -0.64
Tax Burden
 1.00 1.00 0.99 0.91 0.87
Interest Burden
 6.04 6.04 1.02 0.90 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 32.23K 32.23K 0.00 0.00 5.32
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.50
Income Quality
 0.00 0.00 0.00 0.81 0.98
Currency in EUR